Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia - PubMed (original) (raw)
. 2009 Jan 27;106(4):1187-92.
doi: 10.1073/pnas.0807057106. Epub 2009 Jan 15.
Joshua A Regal, Mark Hills, William T Yewdell, Leandro F Dalmazzo, Marco A Zago, Peter M Lansdorp, Donna Hogge, Stephen J Chanock, Elihu H Estey, Roberto P Falcão, Neal S Young
Affiliations
- PMID: 19147845
- PMCID: PMC2627806
- DOI: 10.1073/pnas.0807057106
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia
Rodrigo T Calado et al. Proc Natl Acad Sci U S A. 2009.
Abstract
Loss-of-function mutations in telomerase complex genes can cause bone marrow failure, dyskeratosis congenita, and acquired aplastic anemia, both diseases that predispose to acute myeloid leukemia. Loss of telomerase function produces short telomeres, potentially resulting in chromosome recombination, end-to-end fusion, and recognition as damaged DNA. We investigated whether mutations in telomerase genes also occur in acute myeloid leukemia. We screened bone marrow samples from 133 consecutive patients with acute myeloid leukemia and 198 controls for variations in TERT and TERC genes. An additional 89 patients from a second cohort, selected based on cytogenetic status, and 528 controls were further examined for mutations. A third cohort of 372 patients and 384 controls were specifically tested for one TERT gene variant. In the first cohort, 11 patients carried missense TERT gene variants that were not present in controls (P < 0.0001); in the second cohort, TERT mutations were associated with trisomy 8 and inversion 16. Mutation germ-line origin was demonstrated in 5 patients from whom other tissues were available. Analysis of all 3 cohorts (n = 594) for the most common gene variant (A1062T) indicated a prevalence 3 times higher in patients than in controls (n = 1,110; P = 0.0009). Introduction of TERT mutants into telomerase-deficient cells resulted in loss of enzymatic activity by haploinsufficiency. Inherited mutations in TERT that reduce telomerase activity are risk factors for acute myeloid leukemia. We propose that short and dysfunctional telomeres limit normal stem cell proliferation and predispose for leukemia by selection of stem cells with defective DNA damage responses that are prone to genome instability.
Conflict of interest statement
Conflict of interest statement: P.M.L. declares a financial interest in Repeat Diagnostics, a company specializing in leukocyte telomere length measurements using flow-FISH. The other authors declare no conflict of interest.
Figures
Fig. 1.
TERT mutations in AML. Schematic domain structure of TERT, indicating 3 major regions: N-terminal, reverse transcriptase motifs, and C-terminal. RID denotes RNA-interaction domain and T telomerase-specific motif. Mutation codon locations and amino acid substitutions caused by mutations are shown. Abbreviations for amino acid residues: A, alanine; E, glutamic acid; H, histidine; K, lysine; M, methionine; R, arginine; T, threonine; V, valine.
Fig. 2.
Analysis of TERT gene variants' telomerase enzymatic activity. Telomerase activity of cell lysates made from reconstitution of the wild-type or mutated TERT expression vectors in the telomerase-negative VA13 cell line cotransfected with _TERC_-containing vector was measured by the fluorescent telomeric repeat-amplification protocol (TRAP) assay. Telomerase activity was considered 100% for the wild-type. Each bar (blue) for each vector represents a different transfection experiment and the bar on the top (black) denotes the standard deviation for all experiments for each vector. Telomerase activity in each experiment was corrected for TERT mRNA levels as measured by RT PCR. Cotransfection of wild-type TERT and mutant TERT (R552K Bottom Left and A1062T Bottom Right) at different ratios (indicated below bars) show that telomerase activity is reduced by haploinsufficiency.
Similar articles
- Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
Yamaguchi H, Calado RT, Ly H, Kajigaya S, Baerlocher GM, Chanock SJ, Lansdorp PM, Young NS. Yamaguchi H, et al. N Engl J Med. 2005 Apr 7;352(14):1413-24. doi: 10.1056/NEJMoa042980. N Engl J Med. 2005. PMID: 15814878 - Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
Donaires FS, Scatena NF, Alves-Paiva RM, Podlevsky JD, Logeswaran D, Santana BA, Teixeira AC, Chen JJ, Calado RT, Martinelli ALC. Donaires FS, et al. PLoS One. 2017 Aug 16;12(8):e0183287. doi: 10.1371/journal.pone.0183287. eCollection 2017. PLoS One. 2017. PMID: 28813500 Free PMC article. - Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
Vulliamy TJ, Walne A, Baskaradas A, Mason PJ, Marrone A, Dokal I. Vulliamy TJ, et al. Blood Cells Mol Dis. 2005 May-Jun;34(3):257-63. doi: 10.1016/j.bcmd.2004.12.008. Blood Cells Mol Dis. 2005. PMID: 15885610 - Telomere maintenance and human bone marrow failure.
Calado RT, Young NS. Calado RT, et al. Blood. 2008 May 1;111(9):4446-55. doi: 10.1182/blood-2007-08-019729. Epub 2008 Jan 31. Blood. 2008. PMID: 18239083 Free PMC article. Review. - Telomeres and marrow failure.
Calado RT. Calado RT. Hematology Am Soc Hematol Educ Program. 2009:338-43. doi: 10.1182/asheducation-2009.1.338. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008219 Review.
Cited by
- Intraoperative rapid molecular diagnosis aids glioma subtyping and guides precise surgical resection.
Li J, Han Z, Ma C, Chi H, Jia D, Zhang K, Feng Z, Han B, Qi M, Li G, Li X, Xue H. Li J, et al. Ann Clin Transl Neurol. 2024 Aug;11(8):2176-2187. doi: 10.1002/acn3.52138. Epub 2024 Jun 24. Ann Clin Transl Neurol. 2024. PMID: 38924338 Free PMC article. - Clinical mutations in the TERT and TERC genes coding for telomerase components induced oxidative stress, DNA damage at telomeres and cell apoptosis besides decreased telomerase activity.
Fernández-Varas B, Manguan-García C, Rodriguez-Centeno J, Mendoza-Lupiáñez L, Calatayud J, Perona R, Martín-Martínez M, Gutierrez-Rodriguez M, Benítez-Buelga C, Sastre L. Fernández-Varas B, et al. Hum Mol Genet. 2024 Apr 18;33(9):818-834. doi: 10.1093/hmg/ddae015. Hum Mol Genet. 2024. PMID: 38641551 Free PMC article. - Predicted leukocyte telomere length and risk of myeloid neoplasms.
Sullivan SM, Cole B, Lane J, Meredith JJ, Langer E, Hooten AJ, Roesler M, McGraw KL, Pankratz N, Poynter JN. Sullivan SM, et al. Hum Mol Genet. 2023 Oct 4;32(20):2996-3005. doi: 10.1093/hmg/ddad126. Hum Mol Genet. 2023. PMID: 37531260 Free PMC article. - Telomere dysfunction in some pediatric congenital and growth-related diseases.
Zheng B, Fu J. Zheng B, et al. Front Pediatr. 2023 Apr 3;11:1133102. doi: 10.3389/fped.2023.1133102. eCollection 2023. Front Pediatr. 2023. PMID: 37077333 Free PMC article. Review. - Inherited Chromosomally Integrated Human Herpesvirus 6: Laboratory and Clinical Features.
Gabrielli L, Balboni A, Borgatti EC, Virgili G, Petrisli E, Cantiani A, Pavoni M, Baiesi Pillastrini F, Venturoli S, Piccirilli G, Lazzarotto T. Gabrielli L, et al. Microorganisms. 2023 Feb 21;11(3):548. doi: 10.3390/microorganisms11030548. Microorganisms. 2023. PMID: 36985122 Free PMC article.
References
- Blackburn EH. Switching and signaling at the telomere. Cell. 2001;106:661–673. - PubMed
- Watson JD. Origin of concatemeric T7 DNA. Nat New Biol. 1972;239:197–201. - PubMed
- Heiss NS, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998;19:32–38. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases